The report "Catalyst Monitor Q4 2025" highlights upcoming market opportunities in biotech and pharma, focusing on key approvals and trials such as Cytokinetics’s aficamten, Aldeyra’s reproxalap, and ...
Hybrid water electrolysers are recent devices, which produce hydrogen or other reduction products at the cathode, while ...